Skip to main content

Risperdal Lawsuit: En Banc Hearing Denied: Pa. Superior Court

Risperdal Lawsuit: En Banc Hearing Denied: Pa. Superior Court

 Risperdal Lawsuit: En Banc Hearing Denied: Pa. Superior Court

Introduction

Defendants named in the Risperdal lawsuit, Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, had filed a motion early March requesting a rehearing before the entire Pennsylvania Superior Court for reconsideration of a related January 2018 ruling. On March 16, 2018, the Pennsylvania Superior Court turned down this request.

As per the January 2018 court decision, the court allowed the plaintiff involved in the lawsuit to pursue punitive damages; this decision came after a three-judge panel found that the trial court should have considered the law of plaintiffs’ home states when considering whether or not punitive damages should be allowed. Anticipating thousands of plaintiffs seeking similar awards, the defendants filed a motion to oppose the decision.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.